Literature DB >> 33948777

Facilitators and barriers to medication adherence with adjuvant endocrine therapy in women with breast cancer: a structural equation modelling approach.

Eng Hooi Tan1, Andrea Li Ann Wong2, Chuan Chien Tan3, Patrick Wong4, Sing Huang Tan5, Li En Yvonne Ang2, Siew Eng Lim2, Wan Qin Chong2, Jingshan Ho2, Soo Chin Lee2, Bee Choo Tai6,7.   

Abstract

PURPOSE: To identify a structure to explain the relationship between socio-clinico factors, necessity-concerns beliefs, and perceived barriers to adherence with adjuvant endocrine therapy (AET) amongst women with breast cancer.
METHODS: Participants were 244 patients with early-stage breast cancer recruited from two tertiary hospitals from May 2015 to December 2018 who completed questionnaires on medication adherence (Simplified Medication Adherence Questionnaire), necessity-concerns beliefs (Beliefs about Medicine Questionnaire), and barriers to adherence (Adherence Starts with Knowledge Questionnaire). Socio-clinico variables were collected via interview and medical records review. Structural equation modelling was applied to examine the relationships between these variables and possible mediating effects of necessity-concerns beliefs on adherence to AET.
RESULTS: The median age of the study participants was 61 (range 32-80) years and the median duration on AET was 1.6 (IQR 1.2-2.6) years. Adherence was positively associated with age (β = 0.145, 95% CI: 0.011 to 0.279, p = 0.034) and negatively associated with barriers (β = - 0.381, 95% CI: - 0.511 to - 0.251, p < 0.001). There was no effect of Necessity (β = 0.006, 95% CI: - 0.145 to 0.158, p = 0.933) or Concerns (β = 0.041, 95% CI: - 0.117 to 0.199, p = 0.614) on adherence. Necessity-concerns beliefs were also not significant mediators in the relationship between socio-clinico factors and medication adherence.
CONCLUSIONS: Older age and lower barriers to adherence were associated with higher adherence scores. Necessity-concerns beliefs did not have a significant effect on adherence as majority of the patients identified forgetfulness as a reason for non-adherence.
© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Adherence; Adjuvant endocrine therapy; Breast cancer; Necessity-concerns framework; Structural equation modelling

Mesh:

Substances:

Year:  2021        PMID: 33948777     DOI: 10.1007/s10549-021-06204-9

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  2 in total

1.  Validation on the simplified medication adherence questionnaire (SMAQ) in renal transplant patients on tacrolimus.

Authors:  F J Ortega Suárez; J Sánchez Plumed; M A Pérez Valentín; P Pereira Palomo; M A Muñoz Cepeda; D Lorenzo Aguiar
Journal:  Nefrologia       Date:  2011       Impact factor: 2.033

2.  Beliefs about medicines and adherence in women with breast cancer on adjuvant endocrine therapy.

Authors:  Eng Hooi Tan; Andrea Li Ann Wong; Chuan Chien Tan; Patrick Wong; Sing Huang Tan; Li En Yvonne Ang; Siew Eng Lim; Wan Qin Chong; Jingshan Ho; Soo Chin Lee; Bee Choo Tai
Journal:  J Health Psychol       Date:  2021-02-07
  2 in total
  1 in total

1.  Supporting adjuvant endocrine therapy adherence in women with breast cancer: the development of a complex behavioural intervention using Intervention Mapping guided by the Multiphase Optimisation Strategy.

Authors:  Sophie M C Green; David P French; Christopher D Graham; Louise H Hall; Nikki Rousseau; Robbie Foy; Jane Clark; Catherine Parbutt; Erin Raine; Benjamin Gardner; Galina Velikova; Sally J L Moore; Jacqueline Buxton; Samuel G Smith
Journal:  BMC Health Serv Res       Date:  2022-08-24       Impact factor: 2.908

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.